CompoAtlas

Extrait d'Écorce de Pin 60 Gélules

Food supplement declared in France, declaration No 2019-5-521

Extrait d'Écorce de Pin 60 Gélules (PROZIS) is a food supplement declared in France. Status: withdrawn from the market on 20 February 2024. Main ingredients: Pinus pinaster 200 mg per day. 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
PROZIS
Food business operator placing the product on the market
Prozis.Com, S.A.
Status
Withdrawn from the market on 20 February 2024
Form
Capsule
Daily dose
1 gélule
Directions for use
Prendre 1 gélule par jour.
Intended populations
Men, Women

Declaration 164001, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Pinus pinaster AitonEcorceExtrait sec hydroalcoolique200 mg

Additives

E460, E470b, E171

Other ingredients

gélatine

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ne pas dépasser la portion journalière recommandée. Ce produit ne doit pas remplacer une alimentation variée et équilibrée et un mode de vie sain. Maintenir hors de la portée des enfants. Conserver bien fermé dans l'emballage d'origine dans un endroit frais et sec, à l'abri de la lumière directe du soleil.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : PROZIS

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Extrait d'Écorce de Pin 60 Gélules (PROZIS): composition and regulation”, https://compoatlas.com/en/supplements/products/164001-extrait-d-ecorce-de-pin-60-gelules, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line